Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Joseph J. Ciaffoni
Full-time employees:197
City:Stoughton
Address:100 Technology Center Drive
IPO:2015-05-07
CIK:0001267565
Website:
General Outlook
In simple terms, Collegium Pharmaceutical, Inc. has 31.96 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.575% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.295%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.085%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.042% return, is a testament to Collegium Pharmaceutical, Inc.'s adeptness in optimizing resource deployment. Collegium Pharmaceutical, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.255%. Furthermore, the proficiency of Collegium Pharmaceutical, Inc. in capital utilization is underscored by a remarkable 0.244% return on capital employed.
Stock Prices
Collegium Pharmaceutical, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $38.47, while its low point bottomed out at $37.03. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Collegium Pharmaceutical, Inc.'s stock market.
Liquidity Ratios
Analyzing COLL liquidity ratios reveals its financial health of the firm.
The current ratio of 117.40% gauges short-term asset coverage for liabilities.
The quick ratio (107.02%) assesses immediate liquidity, while the cash ratio (52.18%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
117.40%
Quick Ratio
107.02%
Cash Ratio
52.18%
Profitability Ratios
COLL profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 13.36% underscores its earnings before tax deductions.
The effective tax rate stands at 36.41%, revealing its tax efficiency.
The net income per EBT, 63.59%, and the EBT per EBIT, 45.36%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 29.46%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
13.36%
Effective Tax Rate
36.41%
Net Income per EBT
63.59%
EBT per EBIT
45.36%
EBIT per Revenue
29.46%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.17, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 315.70% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
107
Days of Inventory Outstanding
49
Operating Cycle
164.66
Days of Payables Outstanding
13
Cash Conversion Cycle
151
Receivables Turnover
3.16
Payables Turnover
27.68
Inventory Turnover
7.44
Fixed Asset Turnover
25.75
Asset Turnover
0.50
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 8.51, and free cash flow per share, 8.49, depict cash generation on a per-share basis.
The cash per share value, 9.61, showcases liquidity position.
A payout ratio of 1.19 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, 0.48, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
8.51
Free Cash Flow per Share
8.49
Cash per Share
9.61
Payout Ratio
1.19
Operating Cash Flow Sales Ratio
0.48
Free Cash Flow to Operating Cash Flow Ratio
1.00
Cash Flow Coverage Ratio
0.41
Short Term Coverage Ratio
1.49
Capital Expenditure Coverage Ratio
595.98
Dividend Paid and Capex Coverage Ratio
4.74
Dividend Payout Ratio
0.01
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 58.98%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 3.45, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 71.49%, and total debt to capitalization, 77.53%, ratios shed light on its capital structure.
An interest coverage of 2.00 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
58.98%
Debt Equity Ratio
3.45
Long Term Debt to Capitalization
71.49%
Total Debt to Capitalization
77.53%
Interest Coverage
2.00
Cash Flow to Debt Ratio
0.41
Company Equity Multiplier
5.85
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 16.80, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 1.43, reflects the portion of profit attributed to each share.
The book value per share, 5.79, represents the net asset value distributed per share, while the tangible book value per share, -10.67, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
16.80
Net Income Per Share
1.43
Book Value Per Share
5.79
Tangible Book Value Per Share
-10.67
Shareholders Equity Per Share
5.79
Interest Debt Per Share
22.45
Capex Per Share
-0.01
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 22.17%, indicates top-line expansion, while the gross profit growth, 55.70%, reveals profitability trends.
EBIT growth, 259.66%, and operating income growth, 259.66%, offer insights into operational profitability progression.
The net income growth, 292.60%, showcases bottom-line expansion, and the EPS growth, 293.24%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
22.17%
Gross Profit Growth
55.70%
EBIT Growth
259.66%
Operating Income Growth
259.66%
Net Income Growth
292.60%
EPS Growth
293.24%
EPS Diluted Growth
274.32%
Weighted Average Shares Growth
-0.26%
Weighted Average Shares Diluted Growth
23.53%
Operating Cash Flow Growth
121.16%
Free Cash Flow Growth
123.71%
5-Year Revenue Growth per Share
96.96%
3-Year Revenue Growth per Share
86.43%
10-Year Operating CF Growth per Share
468.04%
5-Year Operating CF Growth per Share
58.06%
3-Year Operating CF Growth per Share
198.25%
10-Year Net Income Growth per Share
165.83%
5-Year Net Income Growth per Share
219.93%
3-Year Net Income Growth per Share
83.56%
10-Year Shareholders Equity Growth per Share
675.25%
5-Year Shareholders Equity Growth per Share
107.95%
3-Year Shareholders Equity Growth per Share
7.13%
3-Year Dividend per Share Growth per Share
26.53%
Receivables Growth
-1.96%
Inventory Growth
-30.47%
Asset Growth
-2.63%
Book Value per Share Growth
0.56%
Debt Growth
-22.74%
R&D Expense Growth
-100.00%
SGA Expenses Growth
-7.54%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,473,890,536.14, captures the company's total value, considering both debt and equity.
Income quality, 5.71, assesses the reliability of reported earnings.
The ratio of intangibles to total assets, 48.59%, indicates the value of non-physical assets, and capex to operating cash flow, -0.17%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
1,473,890,536.14
Income Quality
5.71
Intangibles to Total Assets
48.59%
Capex to Operating Cash Flow
-0.17%
Capex to Revenue
-0.08%
Capex to Depreciation
-0.31%
Stock-Based Compensation to Revenue
4.79%
Graham Number
13.64
Return on Tangible Assets
8.19%
Graham Net Net
-14.42
Working Capital
79,685,000
Tangible Asset Value
-360,134,000
Net Current Asset Value
-410,277,000
Invested Capital
3
Average Receivables
181,322,000
Average Payables
24,157,500
Average Inventory
39,416,500
Days Sales Outstanding
116
Days Payables Outstanding
13
Days of Inventory On Hand
49
ROIC
12.21%
ROE
0.25%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 6.26, and the price to book ratio, 6.26, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 2.13, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 4.41, and price to operating cash flows, 4.45, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
6.26
Price to Book Ratio
6.26
Price to Sales Ratio
2.13
Price Cash Flow Ratio
4.45
Price Earnings to Growth Ratio
1.56
Enterprise Value Multiple
2.33
Price Fair Value
6.26
Price to Operating Cash Flow Ratio
4.45
Price to Free Cash Flows Ratio
4.41
Price to Tangible Book Ratio
5.31
Enterprise Value to Sales
2.60
Enterprise Value Over EBITDA
4.44
EV to Operating Cash Flow
5.36
Earnings Yield
4.64%
Free Cash Flow Yield
26.41%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
